Skip to main content
Top
Published in: International Journal of Colorectal Disease 11/2019

01-11-2019 | Colon Cancer | Original Article

Colon cancer in the young: contributing factors and short-term surgical outcomes

Authors: Kamil Hanna, Muhammad Zeeshan, Mohammad Hamidi, Viraj Pandit, Pamela Omesiete, Alejandro Cruz, Agnes Ewongwo, Bellal Joseph, Valentine Nfonsam

Published in: International Journal of Colorectal Disease | Issue 11/2019

Login to get access

Abstract

Background

The incidence in young patients has increased significantly over the last few decades. The aim of this study is to evaluate demographic and tumor characteristics of young patients and analyze the short-term surgical outcomes of patients undergoing surgery.

Methods

We performed a 2-year review (2015–2016) of the ACS-NSQIP and included all patients with CC who underwent surgical management. Patients were stratified into two groups: early-onset CC (< 50 years old) and late-onset CC (≥ 50 years old). Outcome measures were hospital length of stay, 30-day complications, mortality, and readmission.

Results

We included a total of 15,957 patients in the analysis. Mean age was 65 ± 13 years, and 52% were male. Overall 10% of the patients had early-onset CC. Patients with early-onset CC were more likely to be black (11% vs 7%, p = 0.04) and Hispanic (8% vs 4%, p = 0.02). Additionally, they presented with a more aggressive tumor and higher TNM staging. Patients with early onset CC had lower 30-day complications (18% vs 22%, p = 0.02), shorter hospital length of stay (6[3–8] vs 8[5–11], p = 0.03) and lower 30-day mortality (0.4% vs 1.8%, p = 0.04) compared to their counterparts. However, there was no difference between the two groups regarding 30-day readmission. On regression analysis, there was no difference between the two groups regarding study outcomes.

Conclusions

Racial disparity does exist in the incidence of colon cancer in the young with higher incidence in blacks. Younger patients with CC tend to have better surgical outcomes on univariate analysis. On regression analysis, the surgical outcomes between the two groups are comparable.
Literature
2.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–EE86CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–EE86CrossRef
3.
go back to reference Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34CrossRef Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34CrossRef
4.
go back to reference Haggar FA, Boushey RP (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22(04):191–197CrossRef Haggar FA, Boushey RP (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22(04):191–197CrossRef
5.
go back to reference Segal RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30CrossRef Segal RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30CrossRef
6.
go back to reference Brenner H, Stock C, Hoffmeister M (2014) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Bmj. 348:g2467CrossRef Brenner H, Stock C, Hoffmeister M (2014) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Bmj. 348:g2467CrossRef
7.
go back to reference Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA (2017) Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population-based screening. Clin Gastroenterol Hepatol 15(6):903–909CrossRef Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA (2017) Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population-based screening. Clin Gastroenterol Hepatol 15(6):903–909CrossRef
8.
go back to reference Welch HG, Robertson DJ (2016) Colorectal cancer on the decline—why screening can’t explain it all. N Engl J Med 374(17):1605–1607CrossRef Welch HG, Robertson DJ (2016) Colorectal cancer on the decline—why screening can’t explain it all. N Engl J Med 374(17):1605–1607CrossRef
9.
go back to reference Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM (2014) Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 120(9):1290–1314CrossRef Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM (2014) Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 120(9):1290–1314CrossRef
10.
go back to reference Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T et al (2009) Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27(6):872CrossRef Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T et al (2009) Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27(6):872CrossRef
11.
go back to reference Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343(13):905–914CrossRef Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343(13):905–914CrossRef
12.
go back to reference de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938–2947CrossRef de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938–2947CrossRef
13.
go back to reference Hall WH (1990) Adjuvant therapy for patients with colon and rectal-cancer. JAMA 264(11):1444–1450 Hall WH (1990) Adjuvant therapy for patients with colon and rectal-cancer. JAMA 264(11):1444–1450
14.
go back to reference Ahnen DJ, Wade SW, Jones WF, Sifri R, Silveiras JM, Greenamyer J, Guiffre S, Axilbund J, Spiegel A, You YN (2014) The increasing incidence of youngonset colorectal cancer: a call to action. In Mayo Clinic Proceedings 2014 Feb 1 (Vol. 89, No. 2). Elsevier, Amsterdam, pp 216–224CrossRef Ahnen DJ, Wade SW, Jones WF, Sifri R, Silveiras JM, Greenamyer J, Guiffre S, Axilbund J, Spiegel A, You YN (2014) The increasing incidence of youngonset colorectal cancer: a call to action. In Mayo Clinic Proceedings 2014 Feb 1 (Vol. 89, No. 2). Elsevier, Amsterdam, pp 216–224CrossRef
15.
go back to reference You YN, Xing Y, Feig BW, Chang GJ, Cormier JN (2012) Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med 172(3):287–289CrossRef You YN, Xing Y, Feig BW, Chang GJ, Cormier JN (2012) Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med 172(3):287–289CrossRef
16.
go back to reference Siegel RL, Jemal A, Ward EM (2009) Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiology and Prevention Biomarkers 18(6):1695–1698CrossRef Siegel RL, Jemal A, Ward EM (2009) Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiology and Prevention Biomarkers 18(6):1695–1698CrossRef
17.
go back to reference Bailey CE, Hu C-Y, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ (2015) Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 150(1):17–22CrossRef Bailey CE, Hu C-Y, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ (2015) Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 150(1):17–22CrossRef
18.
go back to reference Deen KI, Silva H, Deen R, Chandrasinghe PC (2016) Colorectal cancer in the young, many questions, few answers. World J Gastrointest Oncol 8(6):481CrossRef Deen KI, Silva H, Deen R, Chandrasinghe PC (2016) Colorectal cancer in the young, many questions, few answers. World J Gastrointest Oncol 8(6):481CrossRef
19.
go back to reference O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY (2003) Rates of colon and rectal cancers are increasing in young adults. Am Surg 69(10):866–872PubMed O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY (2003) Rates of colon and rectal cancers are increasing in young adults. Am Surg 69(10):866–872PubMed
20.
go back to reference Kolligs FT (2016) Diagnostics and epidemiology of colorectal cancer. Visc Med 32(3):158–164CrossRef Kolligs FT (2016) Diagnostics and epidemiology of colorectal cancer. Visc Med 32(3):158–164CrossRef
21.
go back to reference Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiology and Prevention Biomarkers. 25(1):16–27CrossRef Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiology and Prevention Biomarkers. 25(1):16–27CrossRef
22.
go back to reference Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ (2009) Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 7(6):682–8 e1-5CrossRef Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ (2009) Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 7(6):682–8 e1-5CrossRef
23.
go back to reference Shaukat A, Dostal A, Menk J, Church TR (2017) BMI is a risk factor for colorectal cancer mortality. Dig Dis Sci 62(9):2511–2517CrossRef Shaukat A, Dostal A, Menk J, Church TR (2017) BMI is a risk factor for colorectal cancer mortality. Dig Dis Sci 62(9):2511–2517CrossRef
24.
go back to reference Kwan LY, Stratton K, Bonnie RJ (2015) Public health implications of raising the minimum age of legal access to tobacco products. National Academies Press, Washington Kwan LY, Stratton K, Bonnie RJ (2015) Public health implications of raising the minimum age of legal access to tobacco products. National Academies Press, Washington
25.
go back to reference Chung DC (2018) Genetic testing and early onset colon cancer. Gastroenterology. 154(4):788–789CrossRef Chung DC (2018) Genetic testing and early onset colon cancer. Gastroenterology. 154(4):788–789CrossRef
26.
go back to reference Habib R, Gebski V, Toh J, Pathma-Nathan N, Khoury TE, Ctercteko G, Jayamohan J, Wong KYM, Wilcken N, Nagrial A (2019) Outcomes of younger patients diagnosed with locally advanced rectal cancer. Proc Am Soc Clin Oncol 37:500CrossRef Habib R, Gebski V, Toh J, Pathma-Nathan N, Khoury TE, Ctercteko G, Jayamohan J, Wong KYM, Wilcken N, Nagrial A (2019) Outcomes of younger patients diagnosed with locally advanced rectal cancer. Proc Am Soc Clin Oncol 37:500CrossRef
Metadata
Title
Colon cancer in the young: contributing factors and short-term surgical outcomes
Authors
Kamil Hanna
Muhammad Zeeshan
Mohammad Hamidi
Viraj Pandit
Pamela Omesiete
Alejandro Cruz
Agnes Ewongwo
Bellal Joseph
Valentine Nfonsam
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 11/2019
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-019-03402-2

Other articles of this Issue 11/2019

International Journal of Colorectal Disease 11/2019 Go to the issue